- Home
- LXRX vs DOMO Comparison
LXRX vs DOMO Comparison
Compare LXRX & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- DOMO
- Stock Information
- Founded
- LXRX 1995
- DOMO 2010
- Country
- LXRX United States
- DOMO United States
- Employees
- LXRX N/A
- DOMO N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- DOMO Computer Software: Prepackaged Software
- Sector
- LXRX Health Care
- DOMO Technology
- Exchange
- LXRX Nasdaq
- DOMO Nasdaq
- Market Cap
- LXRX 273.9M
- DOMO 286.1M
- IPO Year
- LXRX 2000
- DOMO 2018
- Fundamental
- Price
- LXRX $0.69
- DOMO $7.26
- Analyst Decision
- LXRX Buy
- DOMO Hold
- Analyst Count
- LXRX 2
- DOMO 5
- Target Price
- LXRX $6.00
- DOMO $10.10
- AVG Volume (30 Days)
- LXRX 5.0M
- DOMO 323.3K
- Earning Date
- LXRX 03-10-2025
- DOMO 03-06-2025
- Dividend Yield
- LXRX N/A
- DOMO N/A
- EPS Growth
- LXRX N/A
- DOMO N/A
- EPS
- LXRX N/A
- DOMO N/A
- Revenue
- LXRX $5,229,000.00
- DOMO $318,458,000.00
- Revenue This Year
- LXRX $842.94
- DOMO $0.94
- Revenue Next Year
- LXRX $19.76
- DOMO N/A
- P/E Ratio
- LXRX N/A
- DOMO N/A
- Revenue Growth
- LXRX 886.60
- DOMO 0.01
- 52 Week Low
- LXRX $0.62
- DOMO $6.11
- 52 Week High
- LXRX $3.73
- DOMO $12.23
- Technical
- Relative Strength Index (RSI)
- LXRX 40.93
- DOMO 48.10
- Support Level
- LXRX $0.70
- DOMO $6.54
- Resistance Level
- LXRX $0.75
- DOMO $7.38
- Average True Range (ATR)
- LXRX 0.08
- DOMO 0.26
- MACD
- LXRX -0.00
- DOMO 0.06
- Stochastic Oscillator
- LXRX 7.14
- DOMO 77.42
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.